In our study, we screened out five pseudogenes (ANXA2P2, EEF1A1P9, FER1L4, HILS1, and RAET1K) that were differentially expressed between LGG and GBM and were associated with the prognosis of glioma patients. The gene discussed is ANXA2P2; the disease is glioblastoma.